TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aspergillosis
New findings from University of Texas in the area of aspergillosis described
March 3rd, 2009
According to recent research from the United States, "D.P. Kontoyiannis, V. Ratanatharathorn, J.-A. Young, J. Raymond, M. Laverdiere, D.W. Denning, T.F. Patterson, D. Facklam, L. Kovanda, L. Arnold, W. Lau, D. Buell, K.A. Marr. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.Transpl Infect Dis 2009: 11: 89-93." "All rights reserved We describe herein 98 hematopoietic stem cell transplant (HSCT) recipients with invasive aspergillosis (IA) (refractory in 83) who received micafungin either alone (8 patients) or in combination with other licensed antifungal therapies...
Source: TB & Outbreaks Week (2009-03-03)
|
